Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
or

Nevro Corp (NVRO)

Nevro Corp (NVRO)
5.67 x 1 5.72 x 4
Post-market by (Cboe BZX)
5.72 unch (unch) 02/13/25 [NYSE]
5.67 x 1 5.72 x 4
Post-market 5.71 -0.01 (-0.17%) 19:00 ET
Profile for Thu, Feb 13th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.

Company Info

Nevro Corp 1800 BRIDGE PARKWAY REDWOOD CITY CA 94065 USA

www.nevro.com Employees: 1,215 P: 650-251-0005

Sector:

Medical

Description:

Nevro Corp. is a medical device company which engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg. The company is known for developing and commercializing the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Additionally, the company's HF10 therapy provides long-lasting relief from chronic back and leg pain. Nevro's flagship Senza SCS system has been consistently driving the top line. Since its commercial launch in the United States, the system raked in significant revenues. These apart, Senza is commercially available in Europe since 2010 and in Australia since 2011.

Key Statistics

Overview:

Market Capitalization, $K 214,340
Enterprise Value, $K 321,590
Shares Outstanding, K 37,472
Annual Sales, $ 425,170 K
Annual Net Income, $ -92,210 K
Last Quarter Sales, $ 96,910 K
Last Quarter Net Income, $ -15,340 K
EBIT, $ -84,150 K
EBITDA, $ -75,340 K
60-Month Beta 0.91
% of Insider Shareholders 3.20%
% of Institutional Shareholders 95.52%
Float, K 36,273
% Float 96.80%
Short Volume Ratio 0.07

Growth:

1-Year Return -65.40%
3-Year Return -91.20%
5-Year Return -95.86%
5-Year Revenue Growth 9.78%
5-Year Earnings Growth -50.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.51 on 11/11/24
Next Earnings Date 02/19/25 [--]
Earnings Per Share ttm -1.79
EPS Growth vs. Prev Qtr -18.60%
EPS Growth vs. Prev Year 21.54%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

NVRO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -23.52%
Return-on-Assets % -10.83%
Profit Margin % -21.69%
Debt/Equity 0.81
Price/Sales 0.50
Price/Cash Flow N/A
Price/Book 0.78
Book Value/Share 7.34
Interest Coverage -11.22
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Increase Profitable Opportunities with Barchart's Technical Opinion